Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mildronate for Acute Ischemic Stroke
NCT01831011Phase 2Completed
- Sponsor
- Xijing Hospital
- Start
- Jul 2008
- Primary completion
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of meldonium in ischemic stroke (2 arms), sponsored by Xijing Hospital. Primary endpoint: Modified Rankin Scale at 3 months. Started Jul 2008; status: completed.
02
Drugs
meldonium
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT01831011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01831011.